Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/3/2025

Methadone Maintenance Treatment for Opioid Use Disorder

Cardiac Monitoring Requirements

  • The European Heart Journal recommends ECG evaluation when methadone doses exceed 120 mg/day, with critical cardiac monitoring becoming mandatory for all patients on methadone maintenance 1
  • Baseline ECG is required before initiating methadone to identify QTc prolongation, according to the European Heart Journal and Clinical Infectious Diseases 1, 3
  • Follow-up ECGs should be obtained with dose changes, particularly when approaching or exceeding 100 mg/day, as recommended by the European Heart Journal 1
  • Annual ECGs are recommended for patients with risk factors, according to the European Heart Journal 1
  • Methadone causes dose-dependent QTc prolongation, with risk increasing substantially at higher doses, as reported by the European Heart Journal 1

Dosing Considerations

  • The Centers for Disease Control and Prevention, as reported by MMWR Recommendations and Reports, advise against confusing pain management dosing guidelines with addiction maintenance dosing, noting that the 90 MME/day caution for chronic pain does not apply to methadone maintenance for opioid use disorder 2, 4, 5
  • The American Heart Association, as aligned with the European Heart Journal, recommends against capping doses arbitrarily at 100 or 120 mg/day if patients demonstrate continued illicit opioid use and can safely tolerate higher doses with cardiac monitoring, although this specific guideline is not directly cited, the principle is supported by 1

Contraindications to Dose Escalation

  • The European Heart Journal and Clinical Infectious Diseases recommend stopping dose increases and considering alternatives if QTc exceeds 500 msec, or if QTc is 450-500 msec without correction of reversible causes, or if there is concurrent use of multiple QTc-prolonging medications without cardiology consultation 1, 3, 7